Open AccessA Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
Author(s) -
Fawziah Marra,
Carlo A. Marra,
H Grant Stiver
Publication year - 2003
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2003/453183
Subject(s) - rimantadine , amantadine , medicine , placebo , randomized controlled trial , odds ratio , clinical trial , influenza a virus , virology , virus , pathology , alternative medicine
To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom